Literature DB >> 12509874

Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.

Scott E Hemby1, John Q Trojanowski, Stephen D Ginsberg.   

Abstract

Age-related decline in dopamine receptor levels has been observed in regional studies of animal and human brains; however, identifying specific cellular substrates and/or alterations in distinct neuronal populations remains elusive. To evaluate whether age-related decreases in dopamine receptor subtypes are associated with specific cell populations in the hippocampus and entorhinal cortex, antisense RNA amplification was combined with cDNA array analysis to examine effects of aging on D1-D5 dopamine receptor mRNA expression levels in hippocampal CA1 pyramidal neurons and entorhinal cortex layer II stellate cells from post-mortem human brains (19-92 years). In CA1 pyramidal neurons, significant age-related decline was observed for dopamine receptor mRNAs (D1-D4, P < 0.001; D5, P < 0.05) but not for the cytoskeletal elements beta-actin, three-repeat (3R) tau, and four-repeat (4R) tau. In contrast, no significant changes were observed in stellate cells across the same cohort. Thus, senescence may be a factor responsible for cell-specific decrements in dopamine receptor gene expression in one population of neurons within a circuit that is critical for learning and memory. Furthermore, these results support the hypothesis that alterations in dopaminergic function may also be related to behavioral abnormalities, such as psychosis, that occur with aging. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509874      PMCID: PMC4048549          DOI: 10.1002/cne.10525

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  56 in total

1.  Transient memory impairment in monkeys with bilateral lesions of the entorhinal cortex.

Authors:  B W Leonard; D G Amaral; L R Squire; S Zola-Morgan
Journal:  J Neurosci       Date:  1995-08       Impact factor: 6.167

2.  Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.

Authors:  N D Volkow; G J Wang; J S Fowler; J Logan; S J Gatley; R R MacGregor; D J Schlyer; R Hitzemann; A P Wolf
Journal:  Psychiatry Res       Date:  1996-05-31       Impact factor: 3.222

3.  Dopamine receptor mRNA expression in human striatum and neocortex.

Authors:  J H Meador-Woodruff; S P Damask; J Wang; V Haroutunian; K L Davis; S J Watson
Journal:  Neuropsychopharmacology       Date:  1996-07       Impact factor: 7.853

Review 4.  Aging and the brain: a new frontier.

Authors:  D A Drachman
Journal:  Ann Neurol       Date:  1997-12       Impact factor: 10.422

5.  Age-related and regional differences in dopamine transporter mRNA expression in human midbrain.

Authors:  M J Bannon; C J Whitty
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

6.  Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques.

Authors:  S D Ginsberg; P B Crino; V M Lee; J H Eberwine; J Q Trojanowski
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

7.  Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India.

Authors:  U Muthane; T C Yasha; S K Shankar
Journal:  Ann Neurol       Date:  1998-03       Impact factor: 10.422

8.  Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.

Authors:  D F Wong; G D Pearlson; L E Tune; L T Young; C C Meltzer; R F Dannals; H T Ravert; J Reith; M J Kuhar; A Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  1997-03       Impact factor: 6.200

9.  Coordinated expression of dopamine receptors in neostriatal medium spiny neurons.

Authors:  D J Surmeier; W J Song; Z Yan
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

10.  Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.

Authors:  A Antonini; P Vontobel; M Psylla; I Günther; P R Maguire; J Missimer; K L Leenders
Journal:  Arch Neurol       Date:  1995-12
View more
  26 in total

1.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

2.  Discrete cell gene profiling of ventral tegmental dopamine neurons after acute and chronic cocaine self-administration.

Authors:  Eric Backes; Scott E Hemby
Journal:  J Pharmacol Exp Ther       Date:  2003-09-09       Impact factor: 4.030

Review 3.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

4.  Aging in rhesus macaques is associated with changes in novelty preference and altered saccade dynamics.

Authors:  Nathan Insel; María Luisa Ruiz-Luna; Michelle Permenter; Julie Vogt; Cynthia A Erickson; Carol A Barnes
Journal:  Behav Neurosci       Date:  2008-12       Impact factor: 1.912

Review 5.  Age-related variability in decision-making: Insights from neurochemistry.

Authors:  Anne S Berry; William J Jagust; Ming Hsu
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

Review 6.  Neurocognitive aging: prior memories hinder new hippocampal encoding.

Authors:  Iain A Wilson; Michela Gallagher; Howard Eichenbaum; Heikki Tanila
Journal:  Trends Neurosci       Date:  2006-10-13       Impact factor: 13.837

7.  Region-specific genetic alterations in the aging hippocampus: implications for cognitive aging.

Authors:  Corinna Burger
Journal:  Front Aging Neurosci       Date:  2010-10-14       Impact factor: 5.750

Review 8.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 9.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

10.  Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Keri Ramsey; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine M Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Neurobiol Aging       Date:  2008-06-24       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.